We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > step-down subsidiary

News List

Strides’ subsidiary inks pact with SUDA Pharmaceuticals for migraine drug expressbpd
November 10, 2018
Under the terms of agreement, SUDA will receive an upfront cash payment of $ 0.4 million and a further payment of $ 0.6 million on reaching certain milestones including the pilot first-in-man clinical study, submission and approval of the product in the U
Strides’ subsidiary inks pact with SUDA Pharmaceuticals for migraine drug expressbpd
November 10, 2018
Under the terms of agreement, SUDA will receive an upfront cash payment of $ 0.4 million and a further payment of $ 0.6 million on reaching certain milestones including the pilot first-in-man clinical study, submission and approval of the product in the U